bisbenzimidazole has been researched along with Cancer of Mouth in 1 studies
Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peng, YC | 1 |
| Kuo, HS | 1 |
| Tsai, HD | 1 |
| Yang, YP | 1 |
| Lin, YL | 1 |
1 other study available for bisbenzimidazole and Cancer of Mouth
| Article | Year |
|---|---|
The lethal effect of bis-type azridinylnaphthoquinone derivative on oral cancer cells (OEC-M1) associated with anti-apoptotic protein bcl-2.
Topics: Apoptosis; Bisbenzimidazole; Blotting, Western; Caspase 3; Caspases; Cell Cycle; Cell Line, Tumor; D | 2006 |